Clinical Research of Huangkui Capsule in Treatment of Diabetic Nephropathy with Hyperlipidemia
Sun Xin-yu
Abstract
Sun Xin-yu
Abstract
Objective:To observe the clinical efficacies of Okra(Huangkui capsule)on diabetic nephropathy with hyperlipidemia.Method:One-hundred and six patients of diabetic nephropathic patients who following hyperlip-idemia were randomly divided into control group(50 cases,traditional therapy)and treatment group(56 cases,tradi-tional therapy + Okra),the duration was 24 weeks.triglyceride,total cholesterol,low density lipoprotein and high density lipoprotein were determined in all the patients before and after the treatment.Result:The effective rate of treatment group was 80.36%.There was the obvious reduction in triglyceride,total cholesterol,low density lipopro-tein of the treatment group in some extent(P 0.05).Conclusion:Okra is a better efficient treatment agent for dia-betic nephropathy with hyperlipidemia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the clinical efficacies of Okra(Huangkui capsule)on diabetic nephropathy with hyperlipidemia.Method:One-hundred and six patients of diabetic nephropathic patients who following hyperlip-idemia were randomly divided into control group(50 cases,traditional therapy)and treatment group(56 cases,tradi-tional therapy + Okra),the duration was 24 weeks.triglyceride,total cholesterol,low density lipoprotein and high density lipoprotein were determined in all the patients before and after the treatment.Result:The effective rate of treatment group was 80.36%.There was the obvious reduction in triglyceride,total cholesterol,low density lipopro-tein of the treatment group in some extent(P 0.05).Conclusion:Okra is a better efficient treatment agent for dia-betic nephropathy with hyperlipidemia.
Key concepts: Hyperlipidemia, Medicine, Triglyceride, Diabetic nephropathy, Capsule, Low-density lipoprotein, Internal medicine, Diabetes mellitus